Federal contractor · GREENWOOD, SC

GREENWOOD GENETIC CENTER INC

GREENWOOD GENETIC CENTER INC received $49.4K in federal contract obligations in FY2026, on 1 awards (0% vs FY2025). Since FY2022: $183.5K. Its largest customer was National Institutes of Health ($49.4K). It also received $1.4M in federal grants and other assistance in FY2026.

Obligations · FY2026
$49.4K
New awards
1
Sole-source
100%
Single offer
0.0%
UEI
EAEEYN1KBJT6
Other than small businessNonprofit
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 10KFY2022
  2. 74.8KFY2023
  3. 49.4KFY2025
  4. 49.4KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$49.4K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$49.4K100%

Where the work was performed

  1. Greenwood County, SC$49.4K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $49.4K
  • Sole-source awards100%
    US 30% · $49.4K
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Agencies awarding it sole-source contracts

  1. National Institutes of Health$49.4K
    Department of Health and Human Services · 1 awards

Largest awards

  1. NHGRI: SERVICE: SPECIALIZED GENETIC TESTING FOR UNDIAGNOSED DISEASES: SEVERABLE$49.4K
    National Institutes of Health· Greenwood County, SC· Health & medical· Aug 10, 2026 – Aug 10, 2026· 75N98026P01230

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

GREENWOOD GENETIC CENTER INC received $1.4M in federal assistance in FY2026, on 4 actions (2 new awards), +350% vs FY2025. Its largest program was 93.493 · Congressional Directives ($1.1M).

Assistance · FY2026
$1.4M
New awards
2
Actions
4
Since FY2021
$3.4M

Assistance by fiscal year

  1. 270.4KFY2021
  2. 306.3KFY2022
  3. 542.3KFY2023
  4. 580KFY2024
  5. 308.9KFY2025
  6. 1.4MFY2026

By type

  1. Grants$1.4M100%

Top programs

  1. 93.493 · Congressional Directives$1.1M80%
  2. 93.859 · Biomedical Research and Research Training$284.8K20%

Awarding agencies

  1. Health Resources and Services Administration$1.1M80%
    Department of Health and Human Services
  2. National Institutes of Health$284.8K20%
    Department of Health and Human Services

Largest awards

  1. PATHOGENIC MECHANISMS OF LYSOSOMAL DISEASE - PROJECT SUMMARY MAINTAINING NORMAL ACTIVITY OF LYSOSOMES IS ESSENTIAL FOR HUMAN HEALTH, AS…$1.3M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· May 9, 2022 – Jun 22, 2026· R01NS128907
  2. PROVIDE CRITICAL MEDICAL RESEARCH EQUIPMENT TO SUPPORT THE CARROLL A. CAMPBELL JR. ALZHEIMER?S INITIATIVE, THAT AIMS TO DELIVER A NEW…$1.1M
    93.493 · Congressional Directives· Health Resources and Services Administration· Project grant· Sep 11, 2026 – Sep 11, 2026· GE160077
  3. PATHOGENIC MECHANISMS OF CONGENITAL DISORDERS OF GLYCOSYLATION - THE CONGENITAL DISORDERS OF GLYCOSYLATION (CDG) ARE A GROWING GROUP OF…$516.3K
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Aug 25, 2023 – Jun 11, 2026· R01GM149598
  4. INTERSECTION OF GLYCOSYLATION AND METABOLISM DURING TISSUE DEVELOPMENT - PROTEIN AND LIPID GLYCOSYLATION IS ONE OF THE MOST COMPLEX…$284.8K
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Sep 3, 2026 – Sep 3, 2026· R35GM161481

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

  • Sub-grants: $518.8K (2 subawards)

1 prime

  1. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI$518.8K100%
    NEW YORK, NY · 2 subawards

By fiscal year

  • FY2021: $0 paid out · $1.2M received
  • FY2022: $0 paid out · $186.3K received
  • FY2024: $0 paid out · $421.4K received
  • FY2026: $0 paid out · $518.8K received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

4 companies · $2.3M reported

  1. CLEMSON UNIVERSITY$1.5M
    CLEMSON, SC · 3 subawards
  2. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI$518.8K
    NEW YORK, NY · 2 subawards
  3. UNIVERSITY OF MIAMI$186.3K
    CORAL GABLES, FL · 1 subaward

Showing the top 3 of each list. Open the profile for potential partners and the full lists.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. QUICK BIOLOGY INC$124.9K−100% in FY2026
    MONROVIA, CA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Medical and diagnostic laboratories
  2. CERBA RESEARCH USA, INC$76.6K
    NEW HYDE PARK, NY · 78% of this company's obligations are in markets they both serveNational Institutes of Health · Medical and diagnostic laboratories
  3. ALLAMA IQBAL MEDICAL RESEARCH CENTRE$130K
    LAHORE, PAK · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Medical and diagnostic laboratories

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.